Phase I trial of deuperfenidone (SD 560) in volunteers
Phase of Trial: Phase I
Latest Information Update: 27 Jan 2015
Price : $35 *
At a glance
- Drugs Deupirfenidone (Primary) ; Pirfenidone (Primary)
- Indications Fibrosis; Idiopathic pulmonary fibrosis
- Focus Adverse reactions; Pharmacokinetics
- 27 Jan 2015 Status changed from planning to recruiting, according to the Auspex Pharmaceuticals website.
- 01 Apr 2014 New trial record
- 25 Mar 2014 Early trial results are expected in 2015 according to an Auspex Pharmaceuticals media release.